Prognostic Implication of Semi-quantitative Immunohistochemical Assessment of CD20 Expression in Diffuse Large B-Cell Lymphoma

BACKGROUND: Immunohistochemical demonstration of CD20 in diffuse large B-cell lymphoma (DLBCL) is prerequisite not only for the diagnosis but also for assigning patients to rituximab-containing chemotherapy. However, little is known about the impact of abundance of CD20 expression assessed by immuno...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Chang Hwan, Park, Young Hoon, Lim, Joo Han, Choi, Suk Jin, Kim, Lucia, Park, In Suh, Han, Jee Young, Kim, Joon Mee, Chu, Young Chae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Pathologists and the Korean Society for Cytopathology 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804151/
https://www.ncbi.nlm.nih.gov/pubmed/26875759
http://dx.doi.org/10.4132/jptm.2016.01.12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804151/
https://www.ncbi.nlm.nih.gov/pubmed/26875759
http://dx.doi.org/10.4132/jptm.2016.01.12

Ejemplares similares